Filter byLast updatedSelectAfterBeforeFrom - ToDateEnd DateCategoryHumanCorporateVeterinaryHerbalTopicMedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceAdvanced therapiesClinical trialsCompliance and inspectionsData on medicinesInnovationResearch and developmentBiosimilarsSMEMedicine shortagesAntimicrobial resistanceBrexitQuality of medicinesGeneric and hybrid medicinesGovernanceEarly accessFeesProduct informationCorporateScientific adviceMedicines for use outside the EUMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionProcurementDiseases areaViral diseasesCancerImmune-system diseasesNeurodegenerative diseasesCardiovascular diseasesDiabetesHIV and AIDSTreatment of human immunodeficiency virus type 1 (HIV-1) infectionResponsible bodyCHMPCVMPPRACManagement BoardCOMPPDCOCMDhHMPCCATPatient safetyYesFiltersResults (3643) Sort byLast update date (new to old)Last update date (old to new)A-ZZ-AFourth Meeting of the Management Board of the European Agency for the Evaluation of Medical Products28 October 1994Press releaseCorporateThird Meeting of the Management Board of the European Agency for the Evaluation of Medicinal Products23 June 1994Press releaseCorporateSecond Meeting of the Management Board of the European Agency for the Evaluation of Medicinal Products13 April 1994Press releaseCorporatePrevious357358359360361362363364365
Fourth Meeting of the Management Board of the European Agency for the Evaluation of Medical Products28 October 1994Press releaseCorporate
Third Meeting of the Management Board of the European Agency for the Evaluation of Medicinal Products23 June 1994Press releaseCorporate
Second Meeting of the Management Board of the European Agency for the Evaluation of Medicinal Products13 April 1994Press releaseCorporate